Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1996-6-26
pubmed:abstractText
Synthetic peroxovanadium compounds are a new class of potent inhibitors of protein phosphotyrosine phosphatases. These compounds exhibit insulin-like activity both in vitro and in experimental animals. However, the molecular mechanism by which these compounds exert their biological effect is not well defined. We demonstrate here that several of these compounds induce Xenopus oocyte maturation in vitro, as indicated by germinal vesicle breakdown. Using one of these compounds for further studies, we show that the induction is dose-dependent and is accompanied by activation of maturation promoting factor as well as activation of Xenopus MAP kinase. Like insulin, bpV(pic) causes an acute accumulation of PI(3,4,5)P3 (phosphotidylinositol-3,4,5-trisphosphate), a product of PI 3-kinase. More importantly, bpV(pic)-induced oocyte maturation was abolished by microinjection of a neutralizing monoclonal anti-insulin receptor antibody (17A3) into oocytes or preincubation of oocytes with a PI 3-kinase inhibitor (wortmannin). These results suggest that bpV(pic) acts upstream of the Xenopus IGF-1 receptor in the induction of meiotic maturation, presumably by neutralizing an inhibitory protein tyrosine phosphatase(s) that may regulate the receptor. Finally, using an oocyte-follicle cell complex that responded to human chorionic gonadotropin (hCG) to undergo GVBD, we showed that injection of 17A3 anti-insulin receptor antibody into oocytes did not affect hCG-induced oocyte maturation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Androstadienes, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Calcium-Calmodulin-Dependent..., http://linkedlifedata.com/resource/pubmed/chemical/Chorionic Gonadotropin, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Gonadotropins, Equine, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/Maturation-Promoting Factor, http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol Phosphates, http://linkedlifedata.com/resource/pubmed/chemical/Phosphodiesterase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Phosphotransferases (Alcohol Group..., http://linkedlifedata.com/resource/pubmed/chemical/Protein Tyrosine Phosphatase..., http://linkedlifedata.com/resource/pubmed/chemical/Protein Tyrosine Phosphatases, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, IGF Type 1, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Insulin, http://linkedlifedata.com/resource/pubmed/chemical/Vanadates, http://linkedlifedata.com/resource/pubmed/chemical/peroxovanadate, http://linkedlifedata.com/resource/pubmed/chemical/phosphatidylinositol..., http://linkedlifedata.com/resource/pubmed/chemical/wortmannin
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0012-1606
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
175
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
338-46
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:8626037-Androstadienes, pubmed-meshheading:8626037-Animals, pubmed-meshheading:8626037-Antibodies, Monoclonal, pubmed-meshheading:8626037-Calcium-Calmodulin-Dependent Protein Kinases, pubmed-meshheading:8626037-Chorionic Gonadotropin, pubmed-meshheading:8626037-Dose-Response Relationship, Drug, pubmed-meshheading:8626037-Enzyme Inhibitors, pubmed-meshheading:8626037-Female, pubmed-meshheading:8626037-Gonadotropins, Equine, pubmed-meshheading:8626037-Humans, pubmed-meshheading:8626037-Insulin, pubmed-meshheading:8626037-Maturation-Promoting Factor, pubmed-meshheading:8626037-Microinjections, pubmed-meshheading:8626037-Oogenesis, pubmed-meshheading:8626037-Phosphatidylinositol 3-Kinases, pubmed-meshheading:8626037-Phosphatidylinositol Phosphates, pubmed-meshheading:8626037-Phosphodiesterase Inhibitors, pubmed-meshheading:8626037-Phosphorylation, pubmed-meshheading:8626037-Phosphotransferases (Alcohol Group Acceptor), pubmed-meshheading:8626037-Protein Processing, Post-Translational, pubmed-meshheading:8626037-Protein Tyrosine Phosphatase, Non-Receptor Type 1, pubmed-meshheading:8626037-Protein Tyrosine Phosphatases, pubmed-meshheading:8626037-Receptor, IGF Type 1, pubmed-meshheading:8626037-Receptor, Insulin, pubmed-meshheading:8626037-Second Messenger Systems, pubmed-meshheading:8626037-Vanadates, pubmed-meshheading:8626037-Xenopus laevis
pubmed:year
1996
pubmed:articleTitle
A peroxovanadium compound induces Xenopus oocyte maturation: inhibition by a neutralizing anti-insulin receptor antibody.
pubmed:affiliation
Loeb Medical Research Institute, Ottawa Civic Hospital, Canada.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't